Advanced Enzyme Technologies: Extinguishment of 6,97,582 (Six Lakh Ninety Seven Thousand Five Hundred and Eight Two) fully paid-up Equity…
Advanced Enzyme Technologies (ADVENZYMES) filed a disclosure titled "Extinguishment of 6,97,582 (Six Lakh Ninety Seven Thousand Five Hundred and Eight Two) fully paid-up Equity Shares of the face value of ? 2/- each (Rupees Two Only) of the…". The company is…
What happened
Advanced Enzyme Technologies (ADVENZYMES) filed a disclosure with the exchanges on 5 November 2026 at 11:53 AM titled "Extinguishment of 6,97,582 (Six Lakh Ninety Seven Thousand Five Hundred and Eight Two) fully paid-up Equity Shares of the face value of ? 2/- each (Rupees Two Only) of the…".
Company snapshot
Advanced Enzyme Technologies is a small-cap company in the Healthcare sector, with a market value of about ₹3,048 crore.
The stock last traded at ₹274.3, against a 52-week range of ₹246.8–₹419 (34.5% below the high).
Before this filing the shares had moved 0.0% over the month and −17.6% over three months. Average daily turnover over the last 20 sessions was about ₹6.86 crore.
Promoters held 43.56% at the end of Q2 FY27, up 0.32% points from the previous quarter. Foreign institutions owned 26.65% and domestic institutions 1.89%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q2 FY26 | 185 | 43.3 | 3.87 |
| Q3 FY26 | 172 | 42.5 | 3.8 |
| Q4 FY26 | 203 | 43 | 3.84 |
| Q1 FY27 | 190 | 37.1 | 3.31 |
| Q2 FY27 | 215 | 48.3 | 4.33 |
What history shows
This is not the company's first buyback disclosure: BCEIE has at least 12 earlier filings of this kind on record since May 2026.
After those filings, the stock gained 1.4% on average the next trading day and was up 3.8% on average after five days (12 filings with price data).
Across 7 similar disclosures by other Healthcare companies, shares moved +0.2% on average the next day and +1.5% over five days; 43% of them rose the next day.
Market-wide, 353 buyback filings with an impact score of 50 or more saw an average next-day move of +0.2%, with 56% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 31 Oct 2026 | Post Buyback Public Announcement | +4.1% | — |
| 30 Oct 2026 | Closure of Buyback | +4.1% | — |
| 30 Oct 2026 | Daily Report pursuant to Regulation 18(i) of the Buyback Regulations… | +4.1% | — |
| 29 Oct 2026 | Daily Report pursuant to Regulation 18(i) of the Buyback Regulations… | +6.5% | — |
| 27 Oct 2026 | Daily Report pursuant to Regulation 18(i) of the Buyback Regulations… | +1.3% | — |
In the news
Recent coverage elsewhere (links open the original publisher):
- Advanced Enzyme Tech closes buyback, acquires 24.11 lakh shares for ₹69.7 Cr
- Advanced Enzyme Technologies Ltd. Share Price Live Today
- Advanced Enzyme Technologies Q2 2027 Earnings Call Is Live
- Advanced Enzymes Q2 EBITDA rises 20% as margin reaches 34%
- Earnings call transcript: Advanced Enzyme posts Q2 2026 revenue beat
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.